Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C34H35N3O10.ClH |
Molecular Weight | 682.117 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(=O)C4=C(C=CC=C4OC)C3=O)C(O)=C12)C(C)=NNC(=O)C5=CC=CC=C5)O[C@H]6C[C@H](N)[C@H](O)[C@H](C)O6
InChI
InChIKey=NKFHKYQGZDAKMX-QMFNWPJUSA-N
InChI=1S/C34H35N3O10.ClH/c1-15-28(38)20(35)12-23(46-15)47-22-14-34(44,16(2)36-37-33(43)17-8-5-4-6-9-17)13-19-25(22)32(42)27-26(30(19)40)29(39)18-10-7-11-21(45-3)24(18)31(27)41;/h4-11,15,20,22-23,28,38,40,42,44H,12-14,35H2,1-3H3,(H,37,43);1H/t15-,20-,22-,23-,28+,34-;/m0./s1
Zorubicin is a benzoylhydrazone derivative of the anthracycline antineoplastic antibiotic daunorubicin, but it introduces lower cardiomyopathy and bone marrow toxicity. Zorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair as well as RNA and protein synthesis. The cytotoxic effect results from intercalation between DNA pairs. To minimize toxicity, individualized dose regimens are given preferentially over prolonged periods of time by carefully inspecting i.v. administration to prevent extravasation.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3491 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29200270 |
6.46 µM [IC50] |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1594
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
253-076-4
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
C1458
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
SUB05194MIG
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
100000087889
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
m11665
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | Merck Index | ||
|
164011
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
76964555
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
DTXSID4023755
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
36508-71-1
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
WXM8D9M6DE
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
CHEMBL1697854
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY | |||
|
DBSALT001936
Created by
admin on Fri Dec 15 15:35:05 GMT 2023 , Edited by admin on Fri Dec 15 15:35:05 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD